Allgens Medical Acquires German HumanTech Dental GmbH to Promote the Further Development in the Field of Dental Implantology

News Focus

Recently, Allgens Medical Technology Co., Ltd. (stock code: 688613, hereinafter referred to as "Allgens Medical") agreed to acquire German HumanTech Dental GmbH. (hereinafter referred to as "HT Dental") for a consideration of approximately €3,246,000. After the acquisition is completed, Allgens Medical will hold 100% equity of HT Dental. HT Dental is a German company whose main business is the development and sales of medical devices in the field of dental implantology.

Focusing on industrial integration, market expansion and the need to further expand and strengthen the company, this acquisition of 100% equity of HT Dental in Germany will effectively promote the further development of Allgens Medical's related businesses in the field of dental implants and strengthen the synergy between the two parties, fully unleashing the advantages of transnational technology and marketing, providing customers with a more comprehensive product matrix in the dental field, and accelerating the realization of one-stop solutions from product research and development to large-scale production.

Representatives of both parties signed the equity purchase agreement under the witness of a notary.

Mr. Cui Menglong, general manager of Allgens Medical, said: "We believe that the business in the field of dental implantology has broad development space in China and even around the world. Industrial integration and technological updates represent the future of the pharmaceutical industry. This acquisition of HT Dental not only expands the market , channel expansion, and can also bring excellent brand benefits. In the past two decades, Allgens Medical has been committed to giving full play to the advantages of existing products, technologies, channels, etc., actively expanding business, and using advanced technology and The products benefit more patients. The HT Dental team has very deep technical accumulation and market reputation in the field of dental implantology. We are pleased to further strengthen our capabilities in this area and expand our service scope and customer base through this strategic acquisition .”

Mr. Cui Menglong, general manager of Allgens Medical, and Dr. Georg Hengstberger, head of the seller, were at the signing site

After the completion of this acquisition, HT Dental will become a wholly-owned subsidiary of Allgens Medical. Allgens Medical will continue to develop its business in Stuttgart, Germany, focusing on promoting the development and growth of technology research and development and market sales; HT Dental's management team and all The employees will be retained and will work with the Allgens Medical team on the company's future sustainable development. At the same time, HT Dental will also form synergy with the China headquarters and major subsidiaries of Allgens Medical to further shorten the service radius for overseas customers and significantly improve coverage and service capabilities.

This transaction is expected to be completed in the second quarter of 2024, subject to approval by relevant regulatory authorities.